One of the key scientists on the Missyplicity Project and Genetic Savings & Clone was Dr. Taeyoung Shin, who was born and completed his Ph.D. in South Korea before moving to the United States.
Mira, born December 5, 2007, was the world's first clone of a family dog and bore a striking physical and behavioral resemblance to the original Missy.
In response to this demand, several members of the Missyplicity Project founded Genetic Savings & Clone (GSC) in February 2000.
BioArts and Sooam decided to partner to offer a limited number of cloning spots to the public through a program called "Best Friends Again" in 2008.
[4] In 2009, Lou Hawthorne the CEO of BioArts announced he was withdrawing from the program due to the small market, unethical competition, weak intellectual property protection, unscalable bioethics and unpredictable results.
[5] However Sooam Biotech continued developing proprietary techniques[6] based on a licence from ViaGen's subsidiary Start Licensing (which owns the original Dolly patent[7]) and continued creating cloned dogs for owners whose dogs had died, charging $100,000 a time.